Harrow

Harrow PEG

The PEG Ratio (Price/Earnings-to-Growth) of Harrow (HROW) as of Oct 10, 2026 is -3.02. In the previous year, PEG Ratio (Price/Earnings-to-Growth) was -2.11 — a change of 43.27% (lower).

PEG

-3.02

YoY

43.27%

Last updated:

PEG Ratio (Price/Earnings-to-Growth) of Harrow is 2025 -3.02 . PEG Ratio (Price/Earnings-to-Growth) of Harrow was 2024 -2.11 . It decreases by 43.27% lower compared to the previous year.
Access this data via the Eulerpool API

Harrow Stock analysis

What does Harrow do? Harrow Health Inc is a healthcare company based in San Diego that specializes in the development, manufacturing, and marketing of innovative medical products. The company was founded in 2012 as Imprimis Pharmaceuticals and has since become a significant player in the healthcare market. Harrow is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Harrow stock

PEG Ratio (Price/Earnings-to-Growth) of Harrow is -3.02 in 2025.

PEG Ratio (Price/Earnings-to-Growth) of Harrow changed from -2.11 to -3.02, representing a 43.27% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of PEG Ratio (Price/Earnings-to-Growth) Harrow since 2006 – with annual values, charts, and detailed analysis.

The PEG ratio adjusts the P/E ratio by the expected earnings growth rate. A PEG below 1 may indicate an undervalued stock relative to its growth potential.

PEG = P/E Ratio / Expected Annual EPS Growth Rate

To evaluate PEG Ratio (Price/Earnings-to-Growth)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for PEG Ratio (Price/Earnings-to-Growth).

A 'good' varies by industry and company stage. On Eulerpool, you can compare PEG Ratio (Price/Earnings-to-Growth)'s Harrow with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Valuation — Harrow

All Key Metrics — Harrow